If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTCED.L Regulatory News (TCED)

  • There is currently no data for TCED

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Closure Notice - Tabula Eur IG Perf Credit

22 Feb 2022 10:07

Tabula ICAV - Closure Notice - Tabula Eur IG Perf Credit

Tabula ICAV - Closure Notice - Tabula Eur IG Perf Credit

PR Newswire

London, February 22

TABULA ICAV

5 George’s DockIFSCDublin 1

 

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION.

If you are in any doubt about the course of action to take in relation to this document, you should consult your stockbroker, bank manager, solicitor, accountant or other professional advisor.

If you have sold or transferred your shares in Tabula European IG Performance Credit UCITS ETF (EUR), please pass this document at once to the purchaser or transferee or to the stockbroker, bank or other agent through whom the sale or transfer was effected, for transmission to the purchaser or transferee as soon as possible.

Please note that this notice has not been reviewed by the Central Bank of Ireland (the “Central Bank”).

This notice may also be translated into other languages. Any such translation shall only contain the same information and have the same meaning as the English language notice. To the extent that there is any inconsistency between the English language notice and the notice in another language, the English language notice will prevail. If applicable, please contact your paying agent for a local language version of this notice.

22nd February 2022

Tabula ICAV (the “ICAV”)

Tabula European IG Performance Credit UCITS ETF (EUR) (ISINs: IE00BG0J8M66 and IE00BG0J8L59) (the “Fund”)

 The directors of the ICAV (the “Directors”) wish to inform you of their decision to close the Fund with effect from 14 March 2022 (the “Closure Date”) for the reasons set out below.

Background to the Decision

The Directors have discretion under the ICAV’s instrument of incorporation and the prospectus to redeem all of the shares of a sub-fund of the ICAV (the “Shares”). The Directors, in consultation with KBA Consulting Management Limited and Tabula Investment Management Limited (the “Investment Manager”), have reviewed the ICAV’s sub-fund range and due to the size of the Fund and low levels of investor demand, have resolved to close the Fund in the best interests of shareholders.

Therefore, in accordance with the provisions of the instrument of incorporation and the prospectus for the ICAV, the Directors hereby give notice of their intention to:

1. cancel the listing of the Fund and the right of the Fund to be traded on any relevant stock exchanges with effect from close of business on 10 March 2022; and

2. terminate the Fund with effect from 14 March 2022; and

3. proceed with the compulsory redemption of all outstanding Shares.

Proposed Timetable

DateEvent
10 March 2022Final exchange trading date
11 March 2022Final dealing date (voluntary)
14 March 2022Mandatory redemption trade date (and Closure Date)
25 March 2022Redemption settlement date

Additional Information

Requests for repurchase or subscription for Shares may be made in the usual manner in accordance with the prospectus for the ICAV and the supplement for the Fund until 11 March 2022.

The following terms and conditions of the compulsory redemption of Shares shall apply as at the Closure Date:

1. the Fund shall be terminated and the repurchase price for each class of Shares will be determined by reference to the Net Asset Value of the respective class of Shares as of the Closure Date. The costs in relation to the termination will be borne by the Investment Manager;

2. no repurchase charge will be applied;

3. the repurchase proceeds will be paid in the relevant share class currency;

4. the payment of the repurchase proceeds resulting from the compulsory repurchase will take place on or around 25 March 2022; and

5. following the payment of the repurchase proceeds in respect of the Fund, application will be made to the Central Bank of Ireland for the withdrawal of approval of the Fund.

Shareholders may obtain the prospectus, a copy of the supplement, the key investor information documents, the latest annual and semi-annual reports and copies of the instrument of incorporation free of charge from the registered office of the ICAV or the local representatives in the countries where the ICAV is registered and where applicable on the website of the ICAV – www.tabulaim.com.

Shareholders should consult their own professional advisers as to the specific tax implications of the termination under the laws of the countries of their nationality, residence, domicile or incorporation.

All capitalised terms used in this notice shall bear the same meaning as the capitalised and defined terms used in the prospectus of the ICAV and in the supplement of the Fund.

If you have any queries arising from this notice, please call the Investment Manager on +44 20 3909 4700 or contact us at info@tabulagroup.com.

Yours sincerely

_________________

For and on behalf ofTabula ICAV

 

An open-ended umbrella Irish collective asset-management vehicle with segregated liability between sub-funds formed in Ireland under the Irish Collective Asset-Management Vehicles Act 2015. 

Directors: Barry Harrington, Feargal Dempsey, David Schnautz (German), Michael John Lytle (American), Franco Mancini (Italian)

 Registered in Ireland. Registration No: C174472

Registered Office: as above

Date   Source Headline
5th Jun 20208:01 amRNSNet Asset Value(s)
3rd Jun 20208:17 amRNSNet Asset Value(s)
2nd Jun 20207:47 amRNSNet Asset Value(s)
1st Jun 20207:41 amRNSNet Asset Value(s)
29th May 20207:54 amRNSNet Asset Value(s)
28th May 20207:40 amRNSNet Asset Value(s)
27th May 20207:37 amRNSNet Asset Value(s)
26th May 20207:37 amRNSNet Asset Value(s)
22nd May 20207:44 amRNSNet Asset Value(s)
21st May 20207:33 amRNSNet Asset Value(s)
20th May 20208:12 amRNSNet Asset Value(s)
19th May 20208:03 amRNSNet Asset Value(s)
18th May 20207:50 amRNSNet Asset Value(s)
15th May 20207:36 amRNSNet Asset Value(s)
14th May 20207:40 amRNSNet Asset Value(s)
13th May 20207:21 amRNSNet Asset Value(s)
12th May 20207:33 amRNSNet Asset Value(s)
11th May 20206:27 pmRNSNet Asset Value(s)
11th May 20207:20 amRNSNet Asset Value(s)
7th May 20207:41 amRNSNet Asset Value(s)
6th May 20207:46 amRNSNet Asset Value(s)
5th May 20207:41 amRNSNet Asset Value(s)
1st May 20208:12 amRNSNet Asset Value(s)
29th Apr 20208:00 amRNSNet Asset Value(s)
28th Apr 20207:43 amRNSNet Asset Value(s)
27th Apr 20207:56 amRNSNet Asset Value(s)
24th Apr 20207:46 amRNSNet Asset Value(s)
23rd Apr 202011:07 amRNSNet Asset Value(s)
22nd Apr 20208:36 amRNSNet Asset Value(s)
21st Apr 20208:05 amRNSNet Asset Value(s)
20th Apr 20207:49 amRNSNet Asset Value(s)
17th Apr 20207:33 amRNSNet Asset Value(s)
16th Apr 20207:17 amRNSNet Asset Value(s)
15th Apr 20207:58 amRNSNet Asset Value(s)
14th Apr 20207:32 amRNSNet Asset Value(s)
9th Apr 20207:20 amRNSNet Asset Value(s)
8th Apr 20207:37 amRNSNet Asset Value(s)
7th Apr 20207:32 amRNSNet Asset Value(s)
6th Apr 20207:35 amRNSNet Asset Value(s)
3rd Apr 20208:27 amRNSNet Asset Value(s)
2nd Apr 20207:41 amRNSNet Asset Value(s)
1st Apr 20208:03 amRNSNet Asset Value(s)
31st Mar 20208:03 amRNSNet Asset Value(s)
30th Mar 20207:57 amRNSNet Asset Value(s)
27th Mar 20207:13 amRNSNet Asset Value(s)
26th Mar 20207:23 amRNSNet Asset Value(s)
25th Mar 20207:38 amRNSNet Asset Value(s)
24th Mar 20208:37 amRNSNet Asset Value(s)
23rd Mar 202010:26 amRNSNet Asset Value(s)
20th Mar 20208:24 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.